Copyright © 2001 by the European Society of Cardiology.
Hotline Editorial
Partnership in cardiovascular medicine. A key to success not only for professional organizations
f1 Correspondence: Lars Rydén, Department of Cardiology, Karolinska Hospital, 117 71 Stockholm, Sweden.
References
- Witte K, Thackray S, Clark AL, Cooklin M, Cleland JG. Clinical trials update: IMPROVEMENT-HF, COPERNICUS, MUSTIC, ASPECT-II, APRICOT and HEART. Eur J Heart Fail. 2000;2:455460[CrossRef][ISI][Medline]
- Eur Heart J. 1994;15:13001331
[Free Full Text] - Eur Heart J. 1998;19:14341503
[Free Full Text] - Lancet. 2001;357:9951001[CrossRef][ISI][Medline]
- Eur Heart J. 2000;21:15021513
[Abstract/Free Full Text] - J Am Coll Cardiol. 2000;36:959969
[Free Full Text] - Achutti A, Balaguer-Vintró I, Bayes de Luna A. Challenges and Opportunities for the Prevention and Control of Cardiovascular Diseases in Developing Countries and Economies in Transition. Barcelona: Prous Science; 1990.
- Eur Heart J. 2001;22:554572
[Abstract/Free Full Text] - La Fanu J. The Rise and Fall of Modern Medicine. London: Little Brown & Company; 1999.
- Angell M. Is academic medicine for sale? N Engl J Med. 2000;342:15161518
[Free Full Text] - Angell M. The pharmaceutical industryto whom is it accountable? New Engl J Med. 2000;342:19021904
[Free Full Text]
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||